Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959646 · ClinicalTrials.gov registry record · NA
The Effect of AGE on the Immune System
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT01959646: Completed NA study, sponsored by University of Florida.
NCT01959646 is a NA study that has completed, run by University of Florida. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01959646, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
This is a nutritional intervention study using healthy overweight/obese humans to investigate if a supplement made from aged garlic extract has an impact on immunity. Following a baseline blood draw, participants will consume the capsules (garlic or placebo) for 42 days, at which time a second blood draw will occur. Tests for immune function and inflammation will be performed on both the baseline and 42 day samples. The investigators anticipate that the immune functions and biomarkers that are inflammatory in an overweight/obese population will be returning to normal after 42 days of consumption of this supplement. The investigators predict that AGE supplementation will benefit immunity and improve function while reducing inflammation in a stressed population (inflamed obese).
Primary Outcome
Number and function of gamma delta T-cells and monocytes
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Aged Garlic Extract Supplementation Group
- OTHER Standard for Groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT01959646 record still lists
NCT01959646 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01959646 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01959646 about?
NCT01959646 is a clinical study titled "The Effect of AGE on the Immune System". This is a nutritional intervention study using healthy overweight/obese humans to investigate if a supplement made from aged garlic extract has an impact on immunity. Following a baseline blood draw, participants will consume the capsules (garlic or placebo) for 42 days, at which time a second blood...
What is the current status of trial NCT01959646?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2014-01. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01959646?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Aged Garlic Extract Supplementation Group (DIETARY_SUPPLEMENT), Standard for Groups (OTHER).
Who is sponsoring clinical trial NCT01959646?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01959646's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia